Page last updated: 2024-10-29

ketoconazole and Carcinoma 256, Walker

ketoconazole has been researched along with Carcinoma 256, Walker in 1 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Carcinoma 256, Walker: A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benítez, J1
Muncio, MJ1
Esbrit, P1
Traba, ML1

Other Studies

1 other study available for ketoconazole and Carcinoma 256, Walker

ArticleYear
Role of parathormone-related protein and 1,25-dihydroxyvitamin D in the hypercalcemia of Walker 256 tumor-host rats.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1994, Volume: 26, Issue:6

    Topics: Animals; Calcitriol; Carcinoma 256, Walker; Female; Hypercalcemia; Ketoconazole; Parathyroid Hormone

1994